Size | Price | Stock | Qty |
---|---|---|---|
1mg |
|
||
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
Other Sizes |
|
Purity: ≥98%
Fluorofenidone (AKF-PD; AKFPD), a derivative of AMR69, is a promising multifunctional antifibrosis pyridinone drug that inhibits the pathogenesis of renal interstitial fibrosis by acting as a potent inhibitor of nicotinamide adeninedinucleotide phosphate oxidase via the PI3K/Akt pathway. It slows the development of renal interstitial fibrosis in part by inhibiting NADPH oxidase and the deposition of extracellular matrix (ECM) through the PI3K/Akt signaling pathway.
References |
|
---|
Molecular Formula |
C12H10FNO
|
---|---|
Molecular Weight |
203.2164
|
Exact Mass |
203.0746
|
Elemental Analysis |
C, 70.93; H, 4.96; F, 9.35; N, 6.89; O, 7.87
|
CAS # |
848353-85-5
|
Related CAS # |
Fluorofenidone-d3
|
Appearance |
Solid powder
|
SMILES |
CC1=CN(C(=O)C=C1)C2=CC(=CC=C2)F
|
InChi Key |
JDZYVVUJIQYGRX-UHFFFAOYSA-N
|
InChi Code |
InChI=1S/C12H10FNO/c1-9-5-6-12(15)14(8-9)11-4-2-3-10(13)7-11/h2-8H,1H3
|
Chemical Name |
1-(3-fluorophenyl)-5-methylpyridin-2-one
|
Synonyms |
AKF-PDAKFPD; AKF PD; AMR69 analog; Fluorofenidone
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO: ~140 mg/mL (~688.9 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.33 mg/mL (11.47 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 23.3 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.33 mg/mL (11.47 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 23.3 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.33 mg/mL (11.47 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 4.9208 mL | 24.6039 mL | 49.2078 mL | |
5 mM | 0.9842 mL | 4.9208 mL | 9.8416 mL | |
10 mM | 0.4921 mL | 2.4604 mL | 4.9208 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Different concentrations of test compounds and fluorofenidone were added to the medium, and DMSO was used as a solvent for the test compounds and fluorofenidone, which were applied at a final concentration of 0.1% (v/v) in cell culture medium. Molecules . 2012 Jan 17;17(1):884-96. td> |